Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

1 article from the last 90 days matching "HER2 testing"

ResearchNIH REPORTERMay 11

New NIH Grant: Advanced development and validation of aliquot-level visual indicators of biospecimen exposure to th — $354K at Unknown Institution

Scientists are developing a new tool to help doctors know when frozen tissue and blood samples have thawed or been stored improperly. This matters because many cancer tests, like HER2 testing for breast cancer, require samples to stay fresh and cold. If samples warm up accidentally, the test results could be wrong. This $354,000 research project will create visual indicators—like color-changing labels—that show when a sample has been exposed to unsafe temperatures.

WHY IT MATTERSPatients with breast cancer undergoing HER2 testing depend on properly preserved tissue samples for accurate diagnosis; visual thaw indicators could prevent misdiagnosis caused by specimen degradation.
Good to knowbreast cancer

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases